Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study

Abstract   Among strategies to limit ischemia/reperfusion (IR) injuries in transplantation, cell therapy using stem cells to condition/repair transplanted organs appears promising. We hypothesized that using a cell therapy based on extracellular vesicles (EVs) derived from urine progenitor cells (UP...

Full description

Saved in:
Bibliographic Details
Main Authors: Perrine Burdeyron, Sébastien Giraud, Maryne Lepoittevin, Nina Jordan, Sonia Brishoual, Maïté Jacquard, Virginie Ameteau, Nadège Boildieu, Estelle Lemarie, Jonathan Daniel, Frédéric Martins, Nicolas Mélis, Marine Coué, Raphaël Thuillier, Henri Leuvenink, Luc Pellerin, Thierry Hauet, Clara Steichen
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/ctm2.70095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582250466639872
author Perrine Burdeyron
Sébastien Giraud
Maryne Lepoittevin
Nina Jordan
Sonia Brishoual
Maïté Jacquard
Virginie Ameteau
Nadège Boildieu
Estelle Lemarie
Jonathan Daniel
Frédéric Martins
Nicolas Mélis
Marine Coué
Raphaël Thuillier
Henri Leuvenink
Luc Pellerin
Thierry Hauet
Clara Steichen
author_facet Perrine Burdeyron
Sébastien Giraud
Maryne Lepoittevin
Nina Jordan
Sonia Brishoual
Maïté Jacquard
Virginie Ameteau
Nadège Boildieu
Estelle Lemarie
Jonathan Daniel
Frédéric Martins
Nicolas Mélis
Marine Coué
Raphaël Thuillier
Henri Leuvenink
Luc Pellerin
Thierry Hauet
Clara Steichen
author_sort Perrine Burdeyron
collection DOAJ
description Abstract   Among strategies to limit ischemia/reperfusion (IR) injuries in transplantation, cell therapy using stem cells to condition/repair transplanted organs appears promising. We hypothesized that using a cell therapy based on extracellular vesicles (EVs) derived from urine progenitor cells (UPCs) during hypothermic and normothermic machine perfusion can prevent IR‐related kidney damage. We isolated and characterized porcine UPCs and their extracellular vesicles (EVs). Then these were used in an ex vivo porcine kidney preservation model. Kidneys were subjected to warm ischemia (32 min) and then preserved by hypothermic machine perfusion (HMP) for 24 h before 5 h of normothermic machine perfusion (NMP). Three groups were performed (n = 5–6): Group 1 (G1): HMP/vehicle + NMP/vehicle, Group 2 (G2): HMP/EVs + NMP/vehicle, Group 3 (G3): HMP/EVs + NMP/EVs. Porcine UPCs were successfully isolated from urine and fully characterized as well as their EVs which were found of expected size/phenotype. EVs injection during HMP alone, NMP alone, or both was feasible and safe and did not impact perfusion parameters. However, cell damage markers (LDH, ASAT) were decreased in G3 compared with G1, and G3 kidneys displayed a preserved tissue integrity with reduced tubular dilatation and inflammation notably. However, renal function indicators such as creatinine clearance measured for 5 h of normothermic perfusion or NGAL perfusate's level were not modified by EVs injection. Regarding perfusate analysis, metabolomic analyses and cytokine quantification showed an immunomodulation signature in G3 compared with G1 and highlighted potential metabolic targets. In vitro, EVs as well as perfusates from G3 partially recovered endothelial cell metabolic activity after hypoxia. Finally, RNA‐seq performed on kidney biopsies showed different profiles between G1 and G3 with regulation of potential IR targets of EVs therapy. We showed the feasibility/efficacy of UPC‐EVs for hypothermic/normothermic kidney conditioning before transplantation, paving the way for combining machine perfusion with EVs‐based cell therapy for organ conditioning. Highlights ·UPCs from porcine urine can be used to generate a cell therapy product based on extracellular vesicles (pUPC‐EVs). ·pUPC‐EVs injection during HMP and NMP decreases cell damage markers and has an immunomodulatory effect. ·pUPC‐EVs‐treated kidneys have distinct biochemical, metabolic, and transcriptomic profiles highlighting targets of interest. ·Our results pave the way for combining machine perfusion with EV‐based cell therapy for kidney conditioning.
format Article
id doaj-art-9e9bb7f5dbc942aeb039feedc38d2b2c
institution Kabale University
issn 2001-1326
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj-art-9e9bb7f5dbc942aeb039feedc38d2b2c2025-01-30T03:56:55ZengWileyClinical and Translational Medicine2001-13262024-12-011412n/an/a10.1002/ctm2.70095Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept studyPerrine Burdeyron0Sébastien Giraud1Maryne Lepoittevin2Nina Jordan3Sonia Brishoual4Maïté Jacquard5Virginie Ameteau6Nadège Boildieu7Estelle Lemarie8Jonathan Daniel9Frédéric Martins10Nicolas Mélis11Marine Coué12Raphaël Thuillier13Henri Leuvenink14Luc Pellerin15Thierry Hauet16Clara Steichen17Université de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Bordeaux Institut des Sciences Moléculaires UMR‐5255 Talence FranceUniversité de Bordeaux INSERM PUMA (Transcriptome) Neurocentre Magendie Bordeaux FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceDepartment of Surgery Surgical Research Laboratory University Medical Center Groningen University of Groningen Groningen the NetherlandsUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceUniversité de Poitiers INSERM IRMETIST U1313 CHU de Poitiers Service de Biochimie Poitiers FranceAbstract   Among strategies to limit ischemia/reperfusion (IR) injuries in transplantation, cell therapy using stem cells to condition/repair transplanted organs appears promising. We hypothesized that using a cell therapy based on extracellular vesicles (EVs) derived from urine progenitor cells (UPCs) during hypothermic and normothermic machine perfusion can prevent IR‐related kidney damage. We isolated and characterized porcine UPCs and their extracellular vesicles (EVs). Then these were used in an ex vivo porcine kidney preservation model. Kidneys were subjected to warm ischemia (32 min) and then preserved by hypothermic machine perfusion (HMP) for 24 h before 5 h of normothermic machine perfusion (NMP). Three groups were performed (n = 5–6): Group 1 (G1): HMP/vehicle + NMP/vehicle, Group 2 (G2): HMP/EVs + NMP/vehicle, Group 3 (G3): HMP/EVs + NMP/EVs. Porcine UPCs were successfully isolated from urine and fully characterized as well as their EVs which were found of expected size/phenotype. EVs injection during HMP alone, NMP alone, or both was feasible and safe and did not impact perfusion parameters. However, cell damage markers (LDH, ASAT) were decreased in G3 compared with G1, and G3 kidneys displayed a preserved tissue integrity with reduced tubular dilatation and inflammation notably. However, renal function indicators such as creatinine clearance measured for 5 h of normothermic perfusion or NGAL perfusate's level were not modified by EVs injection. Regarding perfusate analysis, metabolomic analyses and cytokine quantification showed an immunomodulation signature in G3 compared with G1 and highlighted potential metabolic targets. In vitro, EVs as well as perfusates from G3 partially recovered endothelial cell metabolic activity after hypoxia. Finally, RNA‐seq performed on kidney biopsies showed different profiles between G1 and G3 with regulation of potential IR targets of EVs therapy. We showed the feasibility/efficacy of UPC‐EVs for hypothermic/normothermic kidney conditioning before transplantation, paving the way for combining machine perfusion with EVs‐based cell therapy for organ conditioning. Highlights ·UPCs from porcine urine can be used to generate a cell therapy product based on extracellular vesicles (pUPC‐EVs). ·pUPC‐EVs injection during HMP and NMP decreases cell damage markers and has an immunomodulatory effect. ·pUPC‐EVs‐treated kidneys have distinct biochemical, metabolic, and transcriptomic profiles highlighting targets of interest. ·Our results pave the way for combining machine perfusion with EV‐based cell therapy for kidney conditioning.https://doi.org/10.1002/ctm2.70095cell therapyexosomesextracellular vesicleskidney preservationkidney transplantationmachine perfusion
spellingShingle Perrine Burdeyron
Sébastien Giraud
Maryne Lepoittevin
Nina Jordan
Sonia Brishoual
Maïté Jacquard
Virginie Ameteau
Nadège Boildieu
Estelle Lemarie
Jonathan Daniel
Frédéric Martins
Nicolas Mélis
Marine Coué
Raphaël Thuillier
Henri Leuvenink
Luc Pellerin
Thierry Hauet
Clara Steichen
Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
Clinical and Translational Medicine
cell therapy
exosomes
extracellular vesicles
kidney preservation
kidney transplantation
machine perfusion
title Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
title_full Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
title_fullStr Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
title_full_unstemmed Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
title_short Dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells: A proof‐of‐concept study
title_sort dynamic conditioning of porcine kidney grafts with extracellular vesicles derived from urine progenitor cells a proof of concept study
topic cell therapy
exosomes
extracellular vesicles
kidney preservation
kidney transplantation
machine perfusion
url https://doi.org/10.1002/ctm2.70095
work_keys_str_mv AT perrineburdeyron dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT sebastiengiraud dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT marynelepoittevin dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT ninajordan dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT soniabrishoual dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT maitejacquard dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT virginieameteau dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT nadegeboildieu dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT estellelemarie dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT jonathandaniel dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT fredericmartins dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT nicolasmelis dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT marinecoue dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT raphaelthuillier dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT henrileuvenink dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT lucpellerin dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT thierryhauet dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy
AT clarasteichen dynamicconditioningofporcinekidneygraftswithextracellularvesiclesderivedfromurineprogenitorcellsaproofofconceptstudy